(PharmaNewsWire.Com, April 22, 2017 ) Middle-East and Africa Regenerative Medicine Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 23.15% to reach USD 5.75 billion by 2021, from USD 2.03 billion in 2016.
Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma. These medicines restore normal functions of cells & tissues. These medicines are available in different types such as genes, somatic cells, stem cells, and other types.
Some of these medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the original structure of cells or tissues or organs. Regenerative medicines are used in varied range of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology, and orthopaedic, among others.
Majority of the researchers aim to focus on the development of innovative technologies to provide better regenerative medicines and effective healthcare treatment solutions to patients. Key factors which affects and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report.
Some of those factors are Increasing demand for improved healthcare solutions, Rising funding from public & private organizations for the development of advanced healthcare solutions, Government initiatives to promote the development of regenerative medicine products, Inadequate number of healthcare professionals, Insufficient healthcare infrastructure, Low adoption of regenerative medicine products due to poor economic status.
For granular level understanding the Regenerative Medicine Market is segmented based on product, therapy and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Product: Cell-Based Products Autologous Cell-Based Products Allogeneic Cell-Based Products Acellular Products Based on Therapy: Cell Therapy Gene Therapy Tissue Engineering Immunotherapy
Based on Application: Orthopaedic & Musculoskeletal Spine Dermatology Cardiovascular Central Nervous System Oncology Diabetes Other Applications
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and Africa Regenerative Medicine market include Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia). Vertex Pharmaceuticals Incorporated had revenues of $1.7 billion and showed a growth of 65% compared to last year. And recently, CRISPR Therapeutics and Casebia obtained commercial rights to MaxCytes cell engineering platform to develop CRISPR/Cas9-based therapies.
The Middle-East and Africa Regenerative Medicine market report offers wide-range of scope:
Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of product, therapy and application along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
